Abstract

An important application of time-kill curve (TKC) assays is determination of the nature of the best PK/PD index (fAUC/MIC or fT% > MIC) and its target value for predicting clinical efficacy in vivo. VetCAST (the veterinary subcommittee of EUCAST) herein presents semi-mechanistic TKC modeling for florfenicol, a long acting (96 h) veterinary antimicrobial drug licensed against calf pneumonia organisms (Pasteurella multocida and Mannheimia haemolytica) to support justification of its PK/PDbreakpoint and clinical breakpoint. Individual TKC assays were performed with 6 field strains of each pathogen (initial inoculum 107 CFU/mL with sampling at times at 0, 1, 2, 4, 8, and 24 h). Semi-mechanistic modeling (Phoenix NLME) allowed precise estimation of bacteria growth system (KGROWTH, natural growth rate; KDEATH, death rate; BMAX, maximum possible culture size) and florfenicol pharmacodynamic parameters (EMAX, efficacy additive to KDEATH; EC50, potency; Gamma, sensitivity). PK/PD simulations (using the present TKC model and parameters of a florfenicol population pharmacokinetic model) predicted the time-course of bacterial counts under different exposures. Of two licensed dosage regimens, 40 mg/kg administered once was predicted to be superior to 20 mg/kg administered at 48 h intervals. Furthermore, we performed in silico dose fractionation with doses 0 – 80 mg/kg administered in 1, 2 or 4 administrations over 96 h and for MICs of 0.5, 1, 2, 4 mg/L with 2 inoculum sizes 105 and 107 CFU/mL. Regression analysis (Imax model) demonstrated that i) fAUC/MIC outperformed fT% > MIC as PK/PD index and ii) maximum efficacy (IC90%) was obtained when the average free plasma concentration over 96 h was equal to 1.2 to 1.4 times the MIC of Pasteurella multocida and Mannheimia haemolytica, respectively.

Highlights

  • The aim of time–kill in vitro assays is to investigate the pharmacodynamics (PD) of antimicrobial drugs (AMD) by determining the rate of bacterial kill relative to drug concentration

  • The classical and sensitivity. index describing quantitatively AMD action is minimum inhibitory concentration (MIC). These data have been obtained for florfenicol and two major MIC is not a genuine PD parameter; it is a reproducible hybrid variable measured under standard conditions

  • The numerical value of each MIC depends on seven separate factors, as explicitly indicated in eqs. 6A,B

Read more

Summary

Introduction

The aim of time–kill in vitro assays is to investigate the pharmacodynamics (PD) of antimicrobial drugs (AMD) by determining the rate of bacterial kill relative to drug concentration. An important application of TKC data is determination of the best PK/PD index (f AUC/MIC or f T > MIC) for predicting clinical efficacy in vivo, where f AUC is area under plasma concentration-time curve and f T is the time the drug concentration exceeds MIC, for free drug concentrations This has historically been established by correlating the reduction in bacterial count at 24 h from an initial inoculum count (Lees et al, 2015). Plots of log colony forming units (CFU)/mL at 24 h versus each of the two PK/PD indices allowed selection of the PK/PD index which best fits the sigmoidal EMAX model (Lees et al, 2015) This approach was based on the net reduction of bacterial count with each concentration exposure, but did not utilize the time course (i.e., the shape) of individual kill curves. This approach allows characterization the whole concentration-effect relationship

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call